Tech Company Financing Transactions
NeoMend Funding Round
On 1/27/2010, NeoMend raised $30 million in investment from Clarus, Novo Ventures and Prospect Venture Partners.
Transaction Overview
Company Name
Announced On
1/27/2010
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Clarus (Lead Investor) (David Clapper)
Proceeds Purpose
This new funding will move Neomend toward cash flow break-even, as we also pursue approvals for other applications of ProGEL.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
60 Technology Drive
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
NeoMend, Inc. is a privately held, clinical stage biomedical device company engaged in the development and commercialization of advanced surgical wound healing products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Renzi
Chief Financial Officer
Kevin Cousins
VP - Marketing
Mike Nagel
VP - Operations
David Hanson
VP - R & D
Peter Davis
VP - Regulatory Affairs
Pamela Misajon
Browse more venture capital transactions:
Prev: 1/27/2010: CampaignerCRM venture capital transaction
Next: 1/27/2010: Ciris Energy venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs